Abstract:Tumorigenesis is a complex and dynamic process involving cell-cell and cell-extracellular matrix (ECM) interactions that allow tumor cell growth, drug resistance and metastasis. This review provides an updated summary of the role played by the tumor microenvironment (TME) components and hypoxia in tumorigenesis, and highlight various ways through which tumor cells reprogram normal cells into phenotypes that are pro-tumorigenic, including cancer associated- fibroblasts, -macrophages and -endothelial cells. Tumor cells secrete numerous factors leading to the transformation of a previously anti-tumorigenic environment into a pro-tumorigenic environment. Once formed, solid tumors continue to interact with various stromal cells, including local and infiltrating fibroblasts, macrophages, mesenchymal stem cells, endothelial cells, pericytes, and secreted factors and the ECM within the tumor microenvironment (TME). The TME is key to tumorigenesis, drug response and treatment outcome. Importantly, stromal cells and secreted factors can initially be anti-tumorigenic, but over time promote tumorigenesis and induce therapy resistance. To counter hypoxia, increased angiogenesis leads to the formation of new vascular networks in order to actively promote and sustain tumor growth via the supply of oxygen and nutrients, whilst removing metabolic waste. Angiogenic vascular network formation aid in tumor cell metastatic dissemination. Successful tumor treatment and novel drug development require the identification and therapeutic targeting of pro-tumorigenic components of the TME including cancer-associated- fibroblasts (CAFs) and -macrophages (CAMs), hypoxia, blocking ECM-receptor interactions, in addition to the targeting of tumor cells. The reprogramming of stromal cells and the immune response to be anti-tumorigenic is key to therapeutic success. Lastly, this review highlights potential TME- and hypoxia-centered therapies under investigation.

Biophysical interplay between extracellular matrix remodeling and hypoxia signaling in regulating cancer metastasis

Role of the Mechanical Microenvironment in Cancer Development and Progression

Biophysical interactions between components of the tumor microenvironment promote metastasis

Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis

The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression

Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine

Role of Endothelial Cells in the Regulation of Mechanical Microenvironment on Tumor Progression

The relationship between cancer and biomechanics

Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment

Hypoxia disrupt tight junctions and promote metastasis of oral squamous cell carcinoma via loss of par3

The tumor microenvironment and metastatic disease

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Interplay between Solid Tumors and Tumor Microenvironment

Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer

The hypoxic tumour microenvironment and metastatic progression

The Extracellular Matrix and Hypoxia

Mechanical Forces in Tumor Angiogenesis

Insights into the mechanobiology of cancer metastasis via microfluidic technologies

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited

Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond